logo
Share SHARE
FONT-SIZE Plus   Neg

AMAG Pharmaceutocals Reveal Positive Results From Phase III Study Of Feraheme

AMAG Pharmaceuticals Inc (AMAG) Wednesday announced positive preliminary results from the second phase III study for Feraheme in patients with iron deficiency anemia or IDA, regardless of the underlying cause.

The biopharmaceutical company stated that the study, called as IDA-301, compared Feraheme treatment to placebo and enrolled patients having IDA associated with various conditions including abnormal uterine bleeding, cancer, gastrointestinal disorders or other causes.

The company further stated that Feraheme demonstrated superiority on all primary efficacy endpoints evaluated in this study.

The company added that the efficacy and safety of Feraheme in this study were comparable to that reported in the IDA-302 study, the phase III IDA study comparing Feraheme to iron sucrose.

In the IDA-301 study, Feraheme demonstrated robust efficacy, achieving superiority on both primary efficacy endpoints. Patients treated with Feraheme achieved a statistically significant mean increase in hemoglobin at week five of 2.7 g/dL, compared to a mean increase of only 0.1 g/dL in patients who received placebo; importantly, these data are consistent with the 2.7 g/dL increase in hemoglobin reported in the IDA-302 study,

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Aircraft maker Bombardier Inc. (BBD_B.TO, BBD_A.TO) Tuesday revealed an agreement with Air Canada for purchase of Landmark C series for up to 75 aircraft. Air Canada has signed a Letter of Intent in February and placed purchase agreement for 45 CS300 aircraft valued at $3.5 billion, with an option for an additional 30 CS300. The total order value, including option is $6.3 billion at list price. The energy companies are required to disclose payments made to governments for the commercial development of oil, natural gas or minerals, according to rules adopted by the Securities and Exchange Commission. A business woman in California has won $10,000 in settlement with Microsoft, after she filed a lawsuit for automatically updating her business computer to Windows 10, making it slow and hard to use, The Seattle Times reported. Teri Goldstein of Sausalito, a travel agent, had filed a suit, stating that the computer at her travel agency business tried to download the upgrade without her consent...
comments powered by Disqus
Follow RTT